Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.45 USD | +4.06% | -1.17% | +168.84% |
05-09 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
04-29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+168.84% | 1.14B | |
+27.74% | 49.18B | |
+0.73% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.59% | 26.09B | |
-22.52% | 18.71B | |
+7.93% | 13.26B | |
+32.27% | 12.32B | |
-0.18% | 11.99B |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.
- Cullinan Oncology : Morgan Stanley Upgrades Cullinan Management to Overweight from Equalweight, Sets $40 Price Target